These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 20179350)
1. New horizons for studying human hepatotropic infections. de Jong YP; Rice CM; Ploss A J Clin Invest; 2010 Mar; 120(3):650-3. PubMed ID: 20179350 [TBL] [Abstract][Full Text] [Related]
2. Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment. Bissig KD; Wieland SF; Tran P; Isogawa M; Le TT; Chisari FV; Verma IM J Clin Invest; 2010 Mar; 120(3):924-30. PubMed ID: 20179355 [TBL] [Abstract][Full Text] [Related]
3. Chimeric mouse model for the infection of hepatitis B and C viruses. Tesfaye A; Stift J; Maric D; Cui Q; Dienes HP; Feinstone SM PLoS One; 2013; 8(10):e77298. PubMed ID: 24155939 [TBL] [Abstract][Full Text] [Related]
4. Animal model for study of human hepatitis viruses. Chayama K; Hayes CN; Hiraga N; Abe H; Tsuge M; Imamura M J Gastroenterol Hepatol; 2011 Jan; 26(1):13-8. PubMed ID: 21175788 [TBL] [Abstract][Full Text] [Related]
5. A novel TK-NOG based humanized mouse model for the study of HBV and HCV infections. Kosaka K; Hiraga N; Imamura M; Yoshimi S; Murakami E; Nakahara T; Honda Y; Ono A; Kawaoka T; Tsuge M; Abe H; Hayes CN; Miki D; Aikata H; Ochi H; Ishida Y; Tateno C; Yoshizato K; Sasaki T; Chayama K Biochem Biophys Res Commun; 2013 Nov; 441(1):230-5. PubMed ID: 24140055 [TBL] [Abstract][Full Text] [Related]
6. Liver immune-pathogenesis and therapy of human liver tropic virus infection in humanized mouse models. Bility MT; Li F; Cheng L; Su L J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1(0 1):120-4. PubMed ID: 23855307 [TBL] [Abstract][Full Text] [Related]
7. Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera. Meuleman P; Libbrecht L; De Vos R; de Hemptinne B; Gevaert K; Vandekerckhove J; Roskams T; Leroux-Roels G Hepatology; 2005 Apr; 41(4):847-56. PubMed ID: 15791625 [TBL] [Abstract][Full Text] [Related]
8. Factors determining successful engraftment of hepatocytes and susceptibility to hepatitis B and C virus infection in uPA-SCID mice. Vanwolleghem T; Libbrecht L; Hansen BE; Desombere I; Roskams T; Meuleman P; Leroux-Roels G J Hepatol; 2010 Sep; 53(3):468-76. PubMed ID: 20591528 [TBL] [Abstract][Full Text] [Related]
9. Comparative study on the clinical and virological characteristics among patients with single occult hepatitis B virus (HBV), single occult hepatitis C virus (HCV) and occult HBV and HCV dual infection. Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Bartolomé J; Pardo M; Carreño V J Med Virol; 2007 Mar; 79(3):236-41. PubMed ID: 17245725 [TBL] [Abstract][Full Text] [Related]
10. Modeling HBV Infection and Therapy in Immunodeficient NOD-Rag1-/-IL2RgammaC-null (NRG) Fumarylacetoacetate Hydrolase (FAH) Knockout Mice with Human Chimeric Liver. Ahodantin J; Li F; Su L Methods Mol Biol; 2024; 2837():199-206. PubMed ID: 39044086 [TBL] [Abstract][Full Text] [Related]
11. Immune suppression uncovers endogenous cytopathic effects of the hepatitis B virus. Meuleman P; Libbrecht L; Wieland S; De Vos R; Habib N; Kramvis A; Roskams T; Leroux-Roels G J Virol; 2006 Mar; 80(6):2797-807. PubMed ID: 16501088 [TBL] [Abstract][Full Text] [Related]
12. Human Cytotoxic T Lymphocyte-Mediated Acute Liver Failure and Rescue by Immunoglobulin in Human Hepatocyte Transplant TK-NOG Mice. Uchida T; Hiraga N; Imamura M; Tsuge M; Abe H; Hayes CN; Aikata H; Ishida Y; Tateno C; Yoshizato K; Ohdan H; Murakami K; Chayama K J Virol; 2015 Oct; 89(19):10087-96. PubMed ID: 26246560 [TBL] [Abstract][Full Text] [Related]
13. Generation of Human Liver Chimeric Mice for the Study of Human Hepatotropic Pathogens. von Schaewen M; Hrebikova G; Ploss A Methods Mol Biol; 2016; 1438():79-101. PubMed ID: 27150085 [TBL] [Abstract][Full Text] [Related]
14. Occult hepatitis B virus and hepatitis C virus infections. Carreño V; Bartolomé J; Castillo I; Quiroga JA Rev Med Virol; 2008; 18(3):139-57. PubMed ID: 18265423 [TBL] [Abstract][Full Text] [Related]
15. Hepatitis B and C virus-induced hepatitis: Apoptosis, autophagy, and unfolded protein response. Yeganeh B; Rezaei Moghadam A; Alizadeh J; Wiechec E; Alavian SM; Hashemi M; Geramizadeh B; Samali A; Bagheri Lankarani K; Post M; Peymani P; Coombs KM; Ghavami S World J Gastroenterol; 2015 Dec; 21(47):13225-39. PubMed ID: 26715805 [TBL] [Abstract][Full Text] [Related]
16. Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus. Dandri M; Burda MR; Török E; Pollok JM; Iwanska A; Sommer G; Rogiers X; Rogler CE; Gupta S; Will H; Greten H; Petersen J Hepatology; 2001 Apr; 33(4):981-8. PubMed ID: 11283864 [TBL] [Abstract][Full Text] [Related]
17. A chimeric mouse model to study immunopathogenesis of HCV infection. Bility MT; Curtis A; Su L Methods Mol Biol; 2014; 1213():379-88. PubMed ID: 25173399 [TBL] [Abstract][Full Text] [Related]
18. Mice with Chimeric Human Livers and Their Applications. Douglas DN; Kneteman NM Methods Mol Biol; 2019; 1911():459-479. PubMed ID: 30593646 [TBL] [Abstract][Full Text] [Related]
19. Modeling hepatitis virus infections and treatment strategies in humanized mice. Kremsdorf D; Strick-Marchand H Curr Opin Virol; 2017 Aug; 25():119-125. PubMed ID: 28858692 [TBL] [Abstract][Full Text] [Related]
20. Generation of improved mouse models for the study of hepatitis C virus. Douglas DN; Kneteman NM Eur J Pharmacol; 2015 Jul; 759():313-25. PubMed ID: 25814250 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]